FDA approves first treatment option specifically for patients with epithelioid sarcoma
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first treatment for thyroid eye disease
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new treatment for adults with migraine
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first generics of Eliquis
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new type of therapy to treat advanced urothelial cancer
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation
- FDA launches app for health care professionals
- FDA approves first generics of Gilenya
- FDA approves novel treatment to target abnormality in sickle cell disease
- FDA approves first treatment for inherited rare disease
- FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease
- FDA approves first therapy to treat patients with rare blood disorder